S2679 Trends and Disparities in Liver Disease and Hypertension-Related Mortality in Adults ≥65 Years From 1999 to 2023 in the United States

Introduction: Liver disease (LD) and hypertension (HTN) are both common diseases in the United States that heavily influence mortality patterns in adults. The relationship between LD and HTN is multifactorial. Both conditions have shared risk factors that influence disease progression on one another. HTN leads to hepatic microvascular injury, resulting in inflammation and fibrosis. Conversely, LD may influence HTN, though related mechanisms are poorly understood. This study analyses national LD and HTN-related mortality trends among adults ≥65 years from 1999 to 2023. Methods: The CDC WONDER Multiple-Cause-of-Death dataset (1999–2023) was used to assess mortality trends among adults ≥65 years using International Classification of Diseases, Tenth Revision (ICD-10) codes for LD (K70-K76) and HTN (I10-I15). Data was stratified by place of death, year, sex, race, census region, state, and urbanization. Age-adjusted mortality rates (AAMR) were calculated per 100,000 persons by standardizing crude mortality rates (CMR) with 95% confidence intervals (95% CI). Average annual percent change (AAPC) was calculated via the Joinpoint regression model, with statistical significance defined as P < 0.05. Results: A total of 112,506 LD and HTN-related deaths occurred from 1999 to 2023, mainly in medical facilities (38.0%). Overall, AAMR rose from 3.9 in 1999 to 20.3 in 2023 (AAPC: 6.8; 95% CI: 6.3 to 7.3). In terms of age group, adults ≥85 years had the highest average CMR, along with the highest rate of increase (AAPC: 7.4; 95% CI: 6.3 to 8.8). Men, in comparison to women, had higher average AAMR, along with a higher rate of increase (AAPC: 7.5; 95% CI: 6.9 to 8.1). Racially, Hispanic/Latinos had the highest average AAMR, while non-Hispanic (NH) Whites had the highest rate of increase (AAPC: 7.3; 95% CI: 6.8 to 7.9). Regionally, the West had the highest average AAMR, while the South had the highest rate of increase (AAPC: 7.2; 95% CI: 6.8 to 7.8). State-wise, California had the highest percentage of deaths (14.96%). From 1999 to 2020, rural areas, in comparison to urban areas, had higher average AAMR, along with a higher rate of increase (AAPC: 7.4; 95% CI: 6.7 to 8.6). Conclusion: LD and HTN-related mortality among adults ≥65 years increased from 1999 to 2023, with marked disparities across demographic and geographic groups. Such disparities magnify the urgency for targeted interventions and public health policy changes to decrease the mortality burden as a whole and especially among high-risk groups.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001138176.78613.46
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S2679 Trends and Disparities in Liver Disease and Hypertension-Related Mortality in Adults ≥65 Years From 1999 to 2023 in the United States

Muhammad Ali, Komal Khalid, Ammar Nasir, Sadia Ghafur et al.
The American Journal of Gastroenterology
Hepatitis C virus research
article

S2679 Trends and Disparities in Liver Disease and Hypertension-Related Mortality in Adults ≥65 Years From 1999 to 2023 in the United States

Muhammad Ali, Komal Khalid, Ammar Nasir, Sadia Ghafur, Dania Hussain, Saif Ur Rehman, Khizar Hayat, Haider Imran
article en

Abstract

Introduction: Liver disease (LD) and hypertension (HTN) are both common diseases in the United States that heavily influence mortality patterns in adults. The relationship between LD and HTN is multifactorial. Both conditions have shared risk factors that influence disease progression on one another. HTN leads to hepatic microvascular injury, resulting in inflammation and fibrosis. Conversely, LD may influence HTN, though related mechanisms are poorly understood. This study analyses national LD and HTN-related mortality trends among adults ≥65 years from 1999 to 2023. Methods: The CDC WONDER Multiple-Cause-of-Death dataset (1999–2023) was used to assess mortality trends among adults ≥65 years using International Classification of Diseases, Tenth Revision (ICD-10) codes for LD (K70-K76) and HTN (I10-I15). Data was stratified by place of death, year, sex, race, census region, state, and urbanization. Age-adjusted mortality rates (AAMR) were calculated per 100,000 persons by standardizing crude mortality rates (CMR) with 95% confidence intervals (95% CI). Average annual percent change (AAPC) was calculated via the Joinpoint regression model, with statistical significance defined as P < 0.05. Results: A total of 112,506 LD and HTN-related deaths occurred from 1999 to 2023, mainly in medical facilities (38.0%). Overall, AAMR rose from 3.9 in 1999 to 20.3 in 2023 (AAPC: 6.8; 95% CI: 6.3 to 7.3). In terms of age group, adults ≥85 years had the highest average CMR, along with the highest rate of increase (AAPC: 7.4; 95% CI: 6.3 to 8.8). Men, in comparison to women, had higher average AAMR, along with a higher rate of increase (AAPC: 7.5; 95% CI: 6.9 to 8.1). Racially, Hispanic/Latinos had the highest average AAMR, while non-Hispanic (NH) Whites had the highest rate of increase (AAPC: 7.3; 95% CI: 6.8 to 7.9). Regionally, the West had the highest average AAMR, while the South had the highest rate of increase (AAPC: 7.2; 95% CI: 6.8 to 7.8). State-wise, California had the highest percentage of deaths (14.96%). From 1999 to 2020, rural areas, in comparison to urban areas, had higher average AAMR, along with a higher rate of increase (AAPC: 7.4; 95% CI: 6.7 to 8.6). Conclusion: LD and HTN-related mortality among adults ≥65 years increased from 1999 to 2023, with marked disparities across demographic and geographic groups. Such disparities magnify the urgency for targeted interventions and public health policy changes to decrease the mortality burden as a whole and especially among high-risk groups.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 47%
Hepatitis C virus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.